Inspection device
Patent Information
- Application Number
- JP2024507674
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Filing Date
- 2024-09-10
- Publication Date
- 2024-11-21
AI Technical Summary
Automated testing devices face errors and abnormal stops due to the presence of tangible substances in the sample, which can inhibit antigen-antibody reactions and lead to inaccurate test results, especially when formed components like fibrin are aspirated with the plasma or serum.
An inspection device equipped with a nozzle photography camera and a processor that acquires images of the sampling nozzle to detect the presence of formed components, discarding the upper layer containing these substances before re-aspirating the sample, ensuring accurate dispensing into the reaction cell and preventing clogging or pressure detection errors.
This solution effectively suppresses errors and ensures accurate sample aspiration, maintaining the reliability of test results by removing formed components before re-aspiration, thus preventing clogging and pressure detection errors, and ensuring precise antigen-antibody reactions.
Abstract
Description
Inspection Equipment
[0001] The present disclosure relates to an inspection apparatus.
[0002] Testing devices that quantitatively or qualitatively detect target substances in samples are known. Many of these testing devices utilize the principle of immunoassay, such as chemiluminescent enzyme immunoassay devices and fluorescent immunoassay devices (e.g., JP 2016-085093 A).
[0003] In these testing devices, a detection process is performed to detect a target substance in a sample by utilizing an immune reaction to detect luminescence or fluorescence based on a label, such as an enzyme label or a fluorescent label, attached to the target substance in the sample. Furthermore, before this detection process for the target substance, the sample is subjected to a pretreatment process, such as attaching a label to the target substance in the sample. Some testing devices are configured so that the pretreatment and detection processes are automated, and when a sample collection container containing the collected sample is loaded, the pretreatment and detection processes are automatically performed and the detection results are output.
[0004] In such automated testing devices, the following process is performed to label a target substance in a sample, for example, using magnetic particles. First, in a reaction cell, magnetic particles modified with a first binding substance (e.g., a primary antibody) that specifically binds to the target substance (e.g., an antigen) are mixed with the sample, resulting in an antigen-antibody reaction that binds the target substance to the first binding substance, generating an immune complex. This captures the target substance onto the magnetic particles via the first binding substance. Subsequently, so-called B / F (Bound / Free) separation is performed, separating the immune complex from sample-derived components that have not formed an immune complex (unreacted substances). During B / F separation, a magnet placed outside the reaction cell temporarily adsorbs the magnetic particles to the inner wall surface of the reaction cell, and the mixed solution is then aspirated. A wash solution is then dispensed into the reaction cell, and the wash solution and the magnetic particles are mixed together, washing the magnetic particles by aspirating and dispensing the mixed solution. Next, the magnetic particles are mixed with a labeling reagent, which is a second binding substance (e.g., a secondary antibody) that specifically binds to the target substance and contains the second binding substance bound to a label. As a result, the target substance captured on the magnetic particles via the first binding substance binds to the second binding substance, forming a sandwich-type immune complex in which the target substance is sandwiched between the first binding substance and the second binding substance. The magnetic particles are then mixed with a washing solution and washed for B / F separation again. If the label is an enzyme label, the magnetic particles are further mixed with a reagent containing a luminescent substrate and subjected to testing.
[0005] As described above, automated testing devices are equipped with a sample dispenser that aspirates a sample from a sample collection container and dispenses it into a reaction cell. To perform accurate testing, it is desirable that the sample dispensed into the reaction cell does not contain any tangible substances. When the collected sample is whole blood, it is typically separated into blood cells and plasma or blood clots and serum by centrifugation or other processes, and the liquid components, such as serum or plasma, are used for testing. Due to differences in sample transportation conditions and pretreatment conditions, the separated serum or plasma may contain tangible components, such as fibrin. These tangible components often float in the upper layer of the sample and may be aspirated when the serum or plasma is aspirated through the sampling nozzle. These tangible components can clog the sampling nozzle and cause an abnormal stop due to a pressure detection error when detecting the aspirated volume in the sample dispenser. Furthermore, if the immune complex generation process described above is performed while the tangible components are still present, they can inhibit the antigen-antibody reaction, resulting in abnormal test results.
[0006] Japanese Patent Application Laid-Open Publication No. 2015-200527 proposes an inspection device equipped with a detection means for photographing a sample dispensing probe (corresponding to a sampling nozzle) that has sucked and held a sample from a sample container (corresponding to a specimen collection container), and detecting whether a solid object larger than the opening surface of the sample dispensing probe's discharge port is attached to the tip.
[0007] Japanese Patent Application Laid-Open Publication No. 2015-200527 describes that if a solid (equivalent to a tangible object) is found on the tip of the sample dispensing probe, the sample held by the sample dispensing probe is discarded, and the specimen is again aspirated from the sample container to continue the test. However, even if the specimen is again aspirated from the sample container, the solid may again be aspirated into the tip of the sample dispensing probe, which may result in an abnormal stop due to a pressure detection error or an abnormal test result.
[0008] The present invention has been made in consideration of the above circumstances, and aims to provide a testing device that can suppress the occurrence of errors when re-aspirating a sample, even if the sample held in the tip of the sampling nozzle contains tangible matter.
[0009] The testing device of the present disclosure comprises: a detection unit that detects a target substance in a specimen; a specimen dispensing unit that has a sampling nozzle that aspirates the specimen from a specimen collection container and dispenses the specimen into a reaction cell and a moving mechanism that moves the sampling nozzle; a nozzle photographing camera that photographs the sampling nozzle; and a processor that controls the specimen dispensing unit and the nozzle photographing camera, wherein the processor obtains an image of the sampling nozzle holding the specimen from the nozzle photographing camera after the sampling nozzle has aspirated the specimen and before dispensing it into the reaction cell, determines the presence or absence of a formed element in the specimen held by the sampling nozzle based on the image, and if it determines that a formed element is present, controls the specimen dispensing unit to discard the upper layer of the specimen contained in the specimen collection container, which contains the formed element.
[0010] In the testing device of the present disclosure, the processor may be configured to discard the upper layer containing the formed components of the specimen contained in the specimen collection container, and then control the specimen dispensing unit to again aspirate the specimen from the specimen collection container and dispense it into the reaction cell.
[0011] The testing device of the present disclosure may further include an alarm unit that notifies of an error, and the processor may be configured to cause the alarm unit to notify of the presence of a tangible element when it determines that a tangible element is present in the sample held in the sampling nozzle.
[0012] In the testing device of the present disclosure, the specimen may be plasma or serum in whole blood that has been centrifuged in a specimen collection container.
[0013] In the testing device of the present disclosure, the detection unit preferably detects the target substance by utilizing an antigen-antibody reaction to detect luminescence or fluorescence from a label attached to the target substance.
[0014] According to the technology disclosed herein, the testing device can suppress the occurrence of errors when re-aspirating the sample, even if the sample held in the tip of the sampling nozzle contains tangible matter.
[0015] 2A is a schematic diagram showing the configuration of a testing device 10 of an embodiment. FIG. 2A is a top view of a cartridge, and FIG. 2B is a front view. FIG. 2B is a diagram showing a process of labeling a target substance in a reaction cell. FIG. 2C is a diagram for explaining a cleaning process. FIG. 2D is a diagram showing the positional relationship between a nozzle photographing camera and a sampling nozzle. FIG. 2E is a diagram showing the process from aspirating a sample by a sampling nozzle to dispensing it.
[0016] An inspection device according to an embodiment of the present disclosure will be described below with reference to the drawings. In each drawing, components indicated by the same reference numerals are the same components. Unless otherwise specified in the specification, each component is not limited to one, and may be present in multiple numbers.
[0017] 1 is a schematic diagram showing the configuration of an immunoassay device, which is an assay device 10 according to an embodiment of the present disclosure. The assay device 10 is an automated immunoassay device that, after a sample collection container containing a sample collected from a living body is loaded, performs preprocessing to label a target substance in the sample, which is a substance to be detected, then performs detection processing to detect light from the label, and outputs the detection results.
[0018] The testing device 10 includes a sample transport unit 12 , a mixing unit 13 , a sample dispensing unit 14 , a detection unit 15 , a processor 16 , a memory 17 , and a touch panel display 18 .
[0019] The detection unit 15 executes a detection process to detect a target substance A (see FIG. 3, etc.) in the specimen 22. The detection unit 15 includes a photodetector 50 such as a photomultiplier tube or a photodiode. The photodetector 50 is disposed opposite the reaction cell R0 and detects light L resulting from the label S bound to the target substance A. In this example, an enzyme is used as the label S, and chemiluminescence generated by reaction with a luminescent substrate is detected.
[0020] The processor 16 comprehensively controls each part of the inspection device 10. An example of the processor 16 is a CPU (Central Processing Unit) that performs various controls by executing a program. The CPU functions as a control unit that controls each part by executing the program.
[0021] The processor 16 also acquires information about the amount of light L detected by the photodetector 50, and calculates the concentration of the target substance A based on the information about the amount of light.
[0022] The memory 17 is an example of a memory connected to or built into the CPU serving as the processor 16. For example, a control program is stored in the memory 17. In addition to the control program, the memory 17 also stores setting information that is set in advance so that the processor 16 can perform various types of control.
[0023] The memory 17 also stores information indicating the correspondence relationship between the amount of light L detected by the photodetector 50 and the amount of the target substance A. The correspondence relationship is stored, for example, as a calibration curve expressed as a function. The correspondence relationship may also be in the form of a table. The processor 16 calculates the amount of the target substance A, for example, from the amount of light L acquired from the photodetector 50 and the calibration curve stored in the memory 17.
[0024] The touch panel display 18 accepts operational instructions, such as an instruction to start an examination (hereinafter referred to as an examination start instruction), from the user, and also displays information such as examination results.
[0025] The specimen transport unit 12 has a loading section (not shown) into which a specimen collection container 20 containing a specimen 22 is loaded, and transports the loaded specimen collection container 20 to a position accessible by a sampling nozzle 42 (described later) of the specimen dispensing unit 14.
[0026] The specimen 22 is, for example, a body fluid such as blood collected from a living body. The following description will be given of a case in which the specimen 22 is blood, but the specimen 22 is not limited to blood. In this embodiment, the specimen collection container 20 is a blood collection tube. For example, if the blood is whole blood, the whole blood (specimen 22) is separated into components such as blood cells 22a and plasma 22b (see FIG. 6 ) or blood clots and serum by centrifugation or the like, and the plasma or serum is used to test for the target substance. The target substance that may be contained in the specimen 22 and is the test subject may be an antigen, an antibody, a protein, a low molecular weight compound, or the like.
[0027] The mixing unit 13 performs a mixing process, which is performed before the detection process and is performed on the sample 22 in preparation for the detection process, by mixing the magnetic particles MB with a liquid in the reaction cell R0. The mixing process will be described later. The mixing unit 13 includes a loading section (not shown) into which a cartridge RC having a plurality of cells including the reaction cell R0 is loaded, and a reagent dispensing section 13A. In addition to the reaction cell R0, the cartridge RC is provided with cells R1 to R4 that contain various reagents, and openings 30 to 34 of each of the cells R1 to R4 are sealed with a sealing film (not shown).
[0028] The reagent dispensing unit 13A is equipped with a perforation nozzle (not shown) that has a perforation function of piercing and opening a hole in the sealing film provided on the cartridge RC. The perforation nozzle of the reagent dispensing unit 13A repeatedly sucks and discharges the liquid mixed with the magnetic particles MB in the reaction cell R0, thereby performing a mixing process.
[0029] The mixing unit 13 also includes a transport unit 13B. The transport unit 13B transports the cartridge RC to a location where each processing step is performed in the mixing unit 13. Furthermore, the transport unit 13B transports the cartridge RC from the mixing unit 13 to the detection unit 15.
[0030] The specimen dispensing unit 14 performs a specimen dispensing process by aspirating a specimen 22 from a specimen collection container 20 and dispensing it into a cartridge RC loaded in the mixing unit 13. The specimen dispensing unit 14 includes a sampling nozzle 42 and a movement mechanism 46 that moves the sampling nozzle 42. The movement mechanism 46 moves the sampling nozzle 42 vertically (up and down) and horizontally. The vertical and horizontal movements of the sampling nozzle 42 are, for example, performed by linear actuators.
[0031] The sampling nozzle 42, for example, includes a nozzle body 42B and a tip 42A that is replaceably attached to the tip of the nozzle body 42B. The tip of the nozzle body 42B is configured to mate with the base end of the tip 42A. The tip 42A is replaced to prevent contamination of multiple liquids. The tip 42A is a single-use, disposable item. The tip 42A of the sampling nozzle 42 is replaced for each sample 22. In this embodiment, attaching the tip 42A to the tip of the nozzle body 42B of the sampling nozzle 42 is synonymous with attaching the tip 42A to the tip of the sampling nozzle 42. The sample dispensing unit 14 includes a loading unit (not shown) into which the tip 42A is loaded, and the loaded tip 42A is attached to the nozzle body 42B of the sampling nozzle 42.
[0032] The moving mechanism 46 moves the sampling nozzle 42 horizontally between an aspirating position P1 of the sample transport unit 12 and a dispensing position P2 of the mixing unit 13. The aspirating position P1 is a position where the sample 22 is aspirated from the sample collection container 20. The dispensing position P2 is a position where the sample 22 is dispensed into the reaction cell R0 of the cartridge RC set in the mixing unit 13.
[0033] At the aspiration position P1 and the dispensing position P2, the moving mechanism 46 moves the sampling nozzle 42 vertically between an entry position where the tip 42A enters the specimen collection container 20 or the reaction cell R0 and a retract position where the tip 42A retracts from the specimen collection container 20 or the reaction cell R0. At the entry position, the sampling nozzle 42 aspirates and dispenses liquid.
[0034] FIG. 2 is a schematic diagram of the cartridge RC, with FIG. 2A showing a top view of the cartridge RC and FIG. 2B showing a front view of the cartridge RC. The cartridge RC includes a plate-shaped connecting portion 35 with five openings 30-34, and five cylindrical cells R0-R4, each of which has an opening 30-34 at one end and extends downward, including the reaction cell R0. The cartridge RC is configured such that the multiple cells R0-R4 are integrated by the connecting portion 35. Of the multiple cells R0-R4, the reaction cell R0 and cell R1 located at both ends are longer than the other cells R2-R4. The longest cell is the reaction cell R0.
[0035] Before use, the cartridge RC has openings 30 to 34 covered with sealing films (not shown). The cartridge RC is pre-loaded into the testing device 10, and one cartridge RC is used for one specimen 22.
[0036] A sample 22 is dispensed into the reaction cell R0. The reaction cell R0 is a cell in which a process for labeling a target substance in the sample 22 is carried out. The reaction cell R0 contains a mass MC of multiple magnetic particles MB modified with a first binding substance B1 that specifically binds to the target substance. A mixing process is carried out in the reaction cell R0 to mix the magnetic particles MB with a liquid. The mixing process of mixing particles (here, magnetic particles MB) with a liquid is a process carried out to label the target substance in the sample 22. When the magnetic particles MB are spherical, for example, their diameter is about 0.1 to 10 μm, preferably 0.1 to 5 μm, and more preferably 1 to 3 μm.
[0037] Cell R1 contains a buffer solution 36. Cell R2 contains a labeled reagent 37 containing a label S modified with a second binding substance B2 that specifically binds to the target substance. Cell R3 contains a first luminescent reagent 38, and cell R4 contains a second luminescent reagent 39. In this example, the label S is an enzyme, and the label S emits light in the presence of the first luminescent reagent 38 and the second luminescent reagent 39. When it is not necessary to distinguish between the buffer solution 36 in cell R1, the labeled reagent 37 in cell R2, the first luminescent reagent 38 in cell R3, and the second luminescent reagent 39 in cell R4, they will be referred to simply as reagents.
[0038] The first binding substance B1 and the second binding substance B2 that specifically bind to the target substance are, for example, an antibody for the antigen if the target substance is an antigen, an antigen for the antibody if the target substance is an antibody, or an aptamer for the protein or low molecular weight compound if the target substance is a protein or low molecular weight compound, etc. The first binding substance B1 and the second binding substance B2 may be the same or different.
[0039] Here, the process of labeling the target substance in the specimen 22 in the reaction cell R0 will be described with reference to Fig. 3. The steps enclosed by the dashed line in Fig. 3 are steps carried out in the mixing unit 13. Fig. 3 also shows a schematic representation of the reaction in the reaction cell R0. Here, the case where the target substance A is contained in the specimen 22 will be described.
[0040] First, the buffer solution 36 contained in the cell R1 is dispensed into the reaction cell R0 containing the magnetic particles MB modified with the first binding substance B1. Then, the specimen 22 held in the sampling nozzle 42 is dispensed into the reaction cell R0 into which the buffer solution 36 has been dispensed (step ST11).
[0041] In the reaction cell R0, magnetic particles MB, a specimen 22, and a buffer solution 36 are mixed. In the mixture containing the magnetic particles MB, the specimen 22, and the buffer solution 36, a first reaction occurs in which a target substance A in the specimen 22 specifically binds to a first binding substance B1 (step ST12). For example, if the target substance A is an antigen, the first binding substance B1 is an antibody, and the two bind to each other through an antigen-antibody reaction. In this first reaction, the target substance A in the specimen 22 binds to the first binding substance B1, and the target substance A is captured by the magnetic particles MB via the first binding substance B1.
[0042] Next, a first washing process (B / F separation) is carried out to remove unreacted substances other than the target substance A captured by the magnetic particles MB (step ST13). In step ST13 in Fig. 3, the double arrows pointing up and down above the reaction cell R0 schematically show how the liquid in the reaction cell R0 is discharged and how the liquid is supplied to the reaction cell R0.
[0043] Details of the first washing treatment (step ST13) will be described with reference to Fig. 4. In Fig. 4, the target substance A and the first binding substance B1 are not shown.
[0044] A magnet 48 is placed close to the outside of the reaction cell R0 where the first reaction (step ST12) has been completed. As a result, the magnetic particles MB in the reaction cell R0 are attracted to the magnet 48 and collected on the inner wall surface of the side wall to which the magnet 48 is placed close, and magnetic separation is performed to separate the magnetic particles MB from the liquid (step ST1301).
[0045] With the magnetic particles MB attracted to the inner wall surface of the reaction cell R0, the liquid in the reaction cell R0 is discharged (step ST1302).
[0046] After the liquid is discharged from the reaction cell R0, the reaction cell R0 is separated from the magnet 48. At this time, the reaction cell R0 and the magnet 48 are separated to such an extent that the magnetic force of the magnet 48 does not affect the magnetic particles MB in the reaction cell R0. Then, the washing liquid 40 is injected into the reaction cell R0 (step ST1303).
[0047] After the washing liquid 40 is injected into the reaction cell R0, the mixture of the washing liquid 40 and the magnetic particles MB is sucked and discharged, and the magnetic particles MB are re-dispersed in the washing liquid 40 (step ST1304).
[0048] By repeating the steps from magnetic separation (step ST1301) to redispersion (step ST1304) multiple times (for example, about three times), unreacted substances other than the target substance A captured by the magnetic particles MB are removed. B / F separation is performed by the above washing steps, and the magnetic particles MB and the target substance A captured by the magnetic particles MB remain in the reaction cell R0.
[0049] Returning to FIG. 3, the labeled reagent 37 contained in the cell R2 is dispensed into the reaction cell R0 in which the B / F separation has been carried out as described above, and the magnetic particles MB and the labeled reagent 37 are mixed.
[0050] In a mixture containing the labeled reagent 37 and the magnetic particles MB, a binding reaction occurs as a second reaction, in which the target substance A captured by the magnetic particles MB specifically binds to the second binding substance B2 (step ST14). As a result, the target substance A is sandwiched between the first binding substance B1 and the second binding substance B2, and the label S is attached to the target substance A via the second binding substance B2. For example, if the target substance A is an antigen, the second binding substance B2 is an antibody, and the two bind to each other through an antigen-antibody reaction. That is, in this case, the label S is attached to the target substance A using the antigen-antibody reaction.
[0051] Next, a second washing step (B / F separation) is carried out (step ST15) to remove unreacted substances other than the second binding substance B2 bound to the target substance A captured by the magnetic particles MB in the labeled reagent 37. In the second washing process (step ST15), the up-down double arrows shown above the reaction cell R0 schematically show how the liquid in the reaction cell R0 is discharged and supplied to the reaction cell R0, as in step ST13.
[0052] The second washing process (step ST15) is performed in the same manner as the washing process performed in the first washing process (step ST13). That is, magnetic separation is performed by placing a magnet 48 close to the outside of the reaction cell R0, the liquid in the reaction cell R0 is discharged, washing liquid 40 is injected, and the magnetic particles MB are redispersed in the washing liquid 40 (see FIG. 4). In the second washing process (step ST15), the steps from magnetic separation to redispersion are also repeated multiple times (e.g., about three times). This removes unreacted substances other than the label S attached to the target substance A captured by the magnetic particles MB. This second washing process performs B / F separation, leaving the magnetic particles MB, the target substance A captured by the magnetic particles MB, and the label S attached to the target substance A in the reaction cell R0.
[0053] The above steps are the process for attaching the label S to the target substance A in the specimen 22.
[0054] Thereafter, the first luminescent reagent 38 contained in cell R3 and the second luminescent reagent 39 contained in cell R4 are added to reaction cell R0 (step ST16), thereby mixing the magnetic particles MB, the first luminescent reagent 38, and the second luminescent reagent 39.
[0055] The above steps are the pre-treatment performed on the specimen 22 in the reaction cell R0 in the mixing section 13.
[0056] To perform the pretreatment, the mixing unit 13 aspirates and dispenses various liquids using the reagent dispensing unit 13A. For example, as described above, the mixing unit 13 aspirates the cleaning liquid 40 from the cleaning liquid storage unit that stores the cleaning liquid 40 and dispenses the aspirated cleaning liquid 40 into the reaction cell R0, and also aspirates the respective reagents from the cells R1 to R4 and dispenses the aspirated reagents into the reaction cell R0.
[0057] After the above-described pretreatment is completed, the cartridge RC is transported by the transport unit 13B to the detection unit 15 and subjected to the detection treatment in the detection unit 15. In the reaction cell R0, the label S attached to the target substance A reacts with the first luminescent reagent 38 and the second luminescent reagent 39, which are luminescent substrates added in step ST16, to generate chemiluminescence L. The photodetector 50 detects this chemiluminescence L.
[0058] 1, the inspection device 10 is equipped with a nozzle photographing camera 62 that photographs the sampling nozzle 42 to which the tip 42A is attached. The nozzle photographing camera 62 photographs the sampling nozzle 42 from the time the specimen 22 is aspirated by the sampling nozzle 42 until the time the specimen 22 is dispensed into the reaction cell R0. In other words, the nozzle photographing camera 62 photographs the sampling nozzle 42 in a state in which the specimen 22 is held.
[0059] The nozzle photographing camera 62 may be positioned so as to be able to photograph the sampling nozzle 42 from the time when the sample 22 is aspirated by the sampling nozzle 42 until the time when the sample 22 is dispensed. In this embodiment, as shown in Fig. 5, the nozzle photographing camera 62 is positioned so as to be able to photograph the sampling nozzle 42 positioned at the aspirating position P1.
[0060] The processor 16 determines whether or not the specimen 22 contains any tangible components based on an image of the sampling nozzle 42 acquired from the nozzle photographing camera 62. If the processor 16 determines that the specimen 22 contains tangible components F (see FIG. 5), it controls the specimen dispensing unit 14 to discard the upper layer of the specimen 22 contained in the specimen collection container 20, which contains the tangible components F.
[0061] The steps in the testing device 10 from when the sample 22 is aspirated by the sampling nozzle 42 to when the sample 22 is dispensed into the reaction cell R0 will be described with reference to FIG.
[0062] First, in the testing device 10, the tip 42A is attached to the tip of the sampling nozzle 42, in this case the tip of the nozzle body 42B, at a tip attachment position (not shown). The processor 16 controls the movement mechanism 46 to position the sampling nozzle 42 at the suction position P1, move it vertically downward, and insert the tip 42A into the specimen collection container 20. Then, the tip of the tip 42A is positioned at a predetermined suction position, and the specimen 22 is aspirated (step ST1001).
[0063] In this embodiment, the specimen 22 is blood and has been subjected to a centrifugal separation process to separate it into blood cells 22a and plasma 22b. In the specimen collection container 20, the blood cells 22a, which have a larger specific gravity than the plasma 22b, are separated at the bottom side of the specimen collection container 20, and the plasma 22b is separated at the upper side of the blood cells 22a. In this embodiment, liquid plasma 22b is used for testing. Therefore, in step ST1001, the tip of the tip 42A is positioned in the plasma 22b, and the plasma 22b is aspirated.
[0064] Next, the processor 16 controls the moving mechanism 46 to move the sampling nozzle 42 above the specimen collection container 20. Then, the processor 16 controls the nozzle photographing camera 62 to photograph the sampling nozzle 42 in a state in which the specimen 22 (here, plasma 22b) has been aspirated (step ST1002).
[0065] The processor 16 acquires an image PA of the sampling nozzle 42 with the specimen 22 aspirated from the nozzle photographing camera 62, and determines whether or not the specimen 22 contains any formed element F (step ST1003).
[0066] The specimen 22, which is blood that has been centrifuged and stored in the specimen collection container 20, may contain some of the formed components F, such as fibrin, floating in the upper layer. When the plasma 22b is aspirated by the sampling nozzle 42, the formed components F may be aspirated along with the plasma 22b. The processor 16 determines whether or not the specimen 22 (here, the plasma 22b) aspirated by the sampling nozzle 42 contains such formed components F.
[0067] A method for determining whether or not the specimen 22 contains a tangible element F is, for example, to detect fluctuations in brightness in the longitudinal direction (vertical direction) of the sampling nozzle 42 in an image PA of the sampling nozzle 42 holding the specimen 22, and determine that a tangible element is present if there is a location in the specimen 22 where the fluctuation in brightness is greater than or equal to a predetermined threshold value, and determine that a tangible element is not present if there is no location where the fluctuation is greater than or equal to the threshold value.
[0068] If the processor 16 determines that the aspirated specimen 22 contains a tangible component F, it controls the moving mechanism 46 to move the sampling nozzle 42 to a waste liquid processing unit (not shown) and discard the specimen 22 held by the sampling nozzle 42 into a waste liquid storage cell (not shown).The processor 16 then controls the moving mechanism 46 to move the sampling nozzle 42 back to the aspirating position P1, aspirate the upper layer containing the tangible component F of the specimen 22 contained in the specimen collection container 20 (step ST1004), move it to a waste liquid processing unit, and discard it into the waste liquid storage cell.This removes the tangible component F of the specimen 22 from the specimen collection container 20 (step ST1005).
[0069] The processor 16 controls the specimen dispensing unit 14 to replace the tip 42A of the sampling nozzle 42, move the sampling nozzle 42 with the new tip 42A attached to the new tip 42A, and vertically insert the new tip 42A into the specimen collection container 20 to aspirate the specimen 22 (here, plasma 22b) again (step ST1006). Since the particulate matter F in the specimen collection container 20 has already been removed, the re-aspirated specimen 22 does not contain any particulate matter F.
[0070] The processor 16 controls the moving mechanism 46 to move the sampling nozzle 42 holding the re-aspirated specimen 22 to the dispensing position P2, and ejects the specimen 22 into the reaction cell R0 (step ST11 in FIG. 3).
[0071] Furthermore, if the processor 16 determines that there are no formed elements F in the aspirated sample 22, it controls the moving mechanism 46 to move the sampling nozzle 42 holding the sample 22 to the dispensing position P2 and eject the sample 22 into the reaction cell R0.
[0072] When aspirating the upper layer of the specimen 22 from the specimen collection container 20 in step ST1004, the tip 42A used to aspirate the specimen 22 may be discarded, a new tip 42A may be attached to the sampling nozzle 42, and the upper layer of the specimen 22 containing the formed component F may be aspirated using the new tip 42A. In this case, the specimen 22 is again aspirated by replacing the tip 42A.
[0073] After the specimen 22 is discharged into the reaction cell R0, the mixing process is carried out in the mixing section 13, as already explained with reference to FIGS. 3 and 4, and the specimen is subjected to the detection process in the detection section 15.
[0074] If the sample 22 contaminated with the particulate component F is discharged into the reaction cell R0 and the above-described mixing process is performed, the binding between the target substance A and the first binding substance B1 in the first reaction may be inhibited, and the amount of the target substance A captured by the magnetic particles MB may be less than the original amount. Therefore, if a test is performed using the sample 22 contaminated with the particulate component F, the resulting detected amount of the target substance A may be lower than the amount of the target substance A originally contained in the sample 22. In other words, if the mixing process and the detection process are performed using the sample 22 contaminated with the particulate component F of the sample 22, the concentration of the target substance A detected in the detection process may deviate from the actual concentration.
[0075] However, as described above, the testing device 10 includes a nozzle photographing camera 62 that photographs the sampling nozzle 42. When the processor 16 determines that the sample 22 contains a particulate element F, it controls the sample dispensing unit 14 to discard the upper layer of the sample 22 contained in the sample collection container 20, including the particulate element F. This configuration prevents the particulate element F from being suctioned when the sample 22 is re-aspirated, thereby reducing the occurrence of detection errors that may occur when testing is performed with the particulate element F still present in the sample 22, enabling highly reliable testing. Furthermore, during re-aspiration, the particulate element F is aspirated into the sampling nozzle 42, preventing abnormal stops due to pressure detection errors. That is, if the particulate element F is contained in the sample 22 aspirated into the sampling nozzle 42 when the sample 22 is initially aspirated from the sample collection container 20, the upper layer of the sample 22 in the sample collection container 20 is discarded. Therefore, the formed elements F floating in the upper layer of the specimen 22 in the specimen collection container 20 can be discarded, and the occurrence of errors can be reduced when the specimen 22 is aspirated again from the specimen collection container 20.
[0076] In the testing device 10 of this embodiment, the processor 16 discards the upper layer containing the formed components F of the sample 22 contained in the sample collection container 20, and then controls the sample dispensing unit 14 to again aspirate the sample 22 from the sample collection container 20 and dispense it into the reaction cell R0, thereby allowing the testing to continue promptly without delaying the testing.
[0077] In the testing device 10 of the above embodiment, when the processor 16 determines that the sample 22 held in the sampling nozzle 42 contains a tangible element F, the processor 16 may be configured to display an error message on the touch panel display 18 to indicate that the sample 22 contains a tangible element. In this case, the touch panel display 18 constitutes a notification unit that notifies the user of an error. The notification unit that notifies the user of an error may include, separate from the touch panel display 18, a speaker that notifies the user of an error by voice, or a light-emitting unit that notifies the user of an error by light.
[0078] If the system is configured to include a notification unit (here, the touch panel display 18) that notifies of an error, and the processor 16 is configured to use the notification unit to notify of an error indicating the presence of particulate matter F in the specimen 22, the user can be made aware that particulate matter F is floating in the specimen collection container 20. This allows the user to take measures such as adjusting pre-processing conditions, such as the conditions during centrifugation, to suppress the occurrence of floating particulate matter F in the specimen to be subsequently tested.
[0079] The testing device 10 of the above embodiment automatically re-aspirates the sample 22 after discarding the upper layer of the sample collection container 20. However, if the processor 16 is configured to have the notification unit notify that the sample 22 contains a solid component, the testing device 10 may be configured to re-aspirate the sample 22 after a user instruction to re-aspirate the sample 22 is received from an instruction receiving unit such as the touch panel display 18. In this case, the user can confirm the removal status of the solid component F in the upper layer of the sample 22 in the sample collection container 20 before re-aspirating the sample 22, thereby enabling testing to be performed with even higher reliability.
[0080] In the inspection device 10 of the above embodiment, the nozzle photographing camera 62 is disposed in a position where it can photograph the sampling nozzle 42 located at the suction position P1, and photographs the sampling nozzle 42 that has aspirated the specimen 22 at the suction position P1. However, the nozzle photographing camera 62 may be disposed in any position where it can photograph the sampling nozzle 42 holding the specimen 22 after aspirating the specimen 22 and before dispensing the specimen 22. The nozzle photographing camera 62 may also be disposed in a position where it can photograph the sampling nozzle 42 located between the suction position P1 and the dispensing position P2. In this case, the nozzle photographing camera 62 may photograph the sampling nozzle 42 while it is being moved by the movement mechanism 46.
[0081] In the above embodiments, the testing device detects a target substance by detecting luminescence or fluorescence from a label attached to the target substance using an antigen-antibody reaction. However, the present disclosure can also be applied to testing devices that perform biochemical analysis using reactions other than antigen-antibody reactions.
[0082] In each of the above embodiments, the hardware structure of the processor 16 and the processing units that perform various processes as their internal components can be any of the following processors: As described above, the various processors include a CPU, which is a general-purpose processor that executes software to function as various processing units, as well as dedicated electrical circuits that are processors having a circuit configuration designed specifically for performing specific processes, such as a programmable logic device (PLD), which is a processor whose circuit configuration can be changed after manufacture, such as an FPGA (Field Programmable Gate Array), or an ASIC (Application Specific Integrated Circuit).
[0083] A single processing unit may be configured with one of these various processors, or may be configured with a combination of two or more processors of the same or different types (e.g., a combination of multiple FPGAs and / or a combination of a CPU and an FPGA).Furthermore, multiple processing units may be configured with a single processor.
[0084] Examples of configuring multiple processing units with a single processor include, first, a form in which one processor is configured with a combination of one or more CPUs and software, as typified by computers such as client and server, and this processor functions as multiple processing units. Second, a form in which a processor is used to realize the functions of an entire system including multiple processing units with a single IC (Integrated Circuit) chip, as typified by systems on chips (SoCs). In this way, various processing units are configured using one or more of the above-mentioned various processors as a hardware structure.
[0085] Furthermore, more specifically, the hardware structure of these various processors can be an electric circuit (circuitry) that combines circuit elements such as semiconductor elements.
[0086] The present disclosure is not limited to the above embodiments, and can be implemented by making appropriate modifications, such as omitting configurations or replacing them with different configurations, within the scope that does not deviate from the spirit of the present disclosure.
[0087] The disclosure of Japanese Patent Application No. 2022-043030, filed on March 17, 2022, is incorporated herein by reference in its entirety. All documents, patent applications, and technical standards mentioned herein are incorporated herein by reference to the same extent as if each individual document, patent application, and technical standard was specifically and individually indicated to be incorporated by reference.
Claims
1. A detection unit for detecting a target substance in a sample; a specimen dispensing unit having a sampling nozzle that aspirates the specimen from a specimen collection container and dispenses the specimen into a reaction cell, and a moving mechanism that moves the sampling nozzle; a nozzle photographing camera for photographing the sampling nozzle; A processor that controls the sample dispensing unit and the nozzle photographing camera, The processor, acquiring an image of the sampling nozzle holding the sample from the nozzle photographing camera during the period from when the sampling nozzle aspirates the sample to when the sampling nozzle discharges the sample into the reaction cell; determining the presence or absence of formed elements in the sample held by the sampling nozzle based on the image; When it is determined that the formed element is present, the testing device controls the specimen dispensing unit to discard an upper layer containing the formed element of the specimen contained in the specimen collection container.
2. 2. The testing device according to claim 1, wherein the processor controls the specimen dispensing unit to discard an upper layer containing the formed components of the specimen contained in the specimen collection container, and then to aspirate the specimen again from the specimen collection container and dispense it into the reaction cell.
3. Further comprising a notification unit for notifying an error, The testing device according to claim 1 , wherein the processor, when determining that the solid component is present in the sample held by the sampling nozzle, causes the notification unit to notify that the solid component is present.
4. 4. The testing device according to claim 1, wherein the sample is plasma or serum in whole blood that has been subjected to a centrifugal process in the sample collection container.
5. The testing device according to claim 1 , wherein the detection unit detects the target substance by detecting luminescence or fluorescence from a label attached to the target substance using an antigen-antibody reaction.
